ABSTRACT
Liver failure, among other diseases, remains one of the major causes of mortality in the contemporary world. As a consequence of the increase in liver disease incidence, the shortage of donor organs, and the demand for sophisticated transplant teams, interest in hepatocellular therapies is gradually on the rise. These therapies can be categorized under three headings, namely extracorporeal bioartificial liver devices, cell transplantation, and tissue engineering.
